International Centre For Genetic Engineering And Biotechnology

Doing business as Icgeb

UEI
R77WDJ8AW9A1
CAGE
AG022
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
International Organization
SAM.gov registration date
Website
icgeb.org
Founded
1983
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
The Washington University Scope of Work - Sharma lab – ICGEB The overall goal of this study is to identify small molecule inhibitors with appropriate potency, selectivity, and safety… R01AI143857 $0
The Washington University Scope of Work - Sharma lab – ICGEB The overall goal of this study is to identify small molecule inhibitors with appropriate potency, selectivity, and… R01AI143857 $5,400
The Washington University Scope of Work - Sharma lab – ICGEB The overall goal of this study is to identify small molecule inhibitors with appropriate potency, selectivity, and… R01AI143857 $48,600

Similar vendors

About the company

International Centre For Genetic Engineering And Biotechnology, doing business as Icgeb, is an international organization registered as a non-profit entity with the U.S. federal government since December 15, 2006. As a recipient of federal grant sub-awards, Icgeb specializes in genetic engineering and biotechnology research. The organization's expertise lies in structural biology, enzymology, and biochemical studies, particularly focusing on tRNA synthases and their inhibitors. Icgeb collaborates with other research institutions and universities to advance scientific knowledge in areas such as infectious diseases and drug development.

Icgeb has been involved in a significant research project aimed at identifying small molecule inhibitors to cure chronic toxoplasmosis. This work is conducted under a federal grant sub-award from The Washington University, with the project identifier R01AI143857. Dr. Amit Sharma, a co-investigator at Icgeb's Delhi, India facility, leads the biochemical studies on bicyclic azetidine inhibitors. The research involves testing existing and new compounds for inhibition of TG PheRS enzyme in vitro, as well as evaluating top active compounds on mutant TgPheRS, human PheRS, and P. falciparum PheRS. This project showcases Icgeb's capabilities in enzyme inhibition studies, structural biology, and drug discovery, particularly in the context of parasitic diseases. The organization's involvement in this grant demonstrates its role in supporting U.S. federal research initiatives in global health and biotechnology.

Quick answers

Is International Centre For Genetic Engineering And Biotechnology registered in SAM.gov?

International Centre For Genetic Engineering And Biotechnology's SAM.gov registration expired on March 30, 2024.

On GovTribe

See International Centre For Genetic Engineering And Biotechnology's full federal record

  • Similar vendors